BioSpace News Archive

FDA

FDA approves the first drug with an indication for treatment of smallpox

The U.S. Food and Drug Administration today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox.

July 13, 2018
·
3 min read
Business

Sangamo Therapeutics Announces Technology Leadership Changes

Sangamo Therapeutics, Inc. announced that Michael Holmes, Ph.D., Senior Vice President and Chief Technology Officer, will resign from the Company effective July 20th to pursue an opportunity with a startup biotech company.

July 13, 2018
·
2 min read
Deals

ArQule Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

ArQule, Inc. announced the closing of its previously announced underwritten public offering of common stock, including the exercise in full by the underwriters of their option to purchase an additional 1,650,000 shares at the public offering price of $5.50 per share.

July 13, 2018
·
4 min read
Global Generic Drugs Market 2018-2022| Availability of Low-cost Alternatives to Promote Growth| Technavio

The global generic drugs market is expected to post a CAGR of more than 10% during the period 2018-2022, according to the latest market research report by Technavio.

July 13, 2018
·
4 min read
Business

Torchmark Corporation Announces Second Quarter 2018 Earnings Release And Conference Call

Torchmark Corporation will release Second Quarter 2018 earnings after the market closes on Wednesday, July 25, 2018.

July 13, 2018
·
1 min read
FDA

FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

The U.S. Food and Drug Administration (FDA) is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure.

July 13, 2018
·
4 min read
Business

Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018

Luminex Corporation announced that it expects to report results for the second quarter ended June 30, 2018 on Monday, August 6, 2018.

July 13, 2018
·
1 min read
Policy

Statement on event sponsorship and other promotional activities by federally licensed producers of cannabis

Health Canada is concerned by the decision of some federally licensed producers of cannabis for medical purposes to sponsor events, such as music festivals, and engage in other promotional activities, as reported recently by several Canadian media outlets.

July 13, 2018
·
1 min read
Policy

U.S. FDA Extends Review Timeline for INVOKANA® (canagliflozin) Supplemental New Drug Application

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for a supplemental New Drug Application (sNDA) for INVOKANA®

July 13, 2018
·
9 min read
Business

Nevro to Announce Preliminary Second Quarter Worldwide Revenue, Discuss Full Year 2018 Revenue Guidance and Provide Business Updates

Company to Host Conference Call on Monday, July 16, 2018 at 5:30 a.m. PT / 8:30 a.m. ET

July 13, 2018
·
1 min read